Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Pfizer
|
| gptkbp:acquisitionYear |
2016
|
| gptkbp:BIND-014Indication |
gptkb:cancer
|
| gptkbp:focusesOn |
nanomedicine
targeted drug delivery |
| gptkbp:foundedBy |
gptkb:Robert_Langer
gptkb:Omid_Farokhzad |
| gptkbp:foundedYear |
2006
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
BIND Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:BIND-014
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:BIND
|
| gptkbp:website |
www.bindtherapeutics.com
|
| gptkbp:bfsParent |
gptkb:Omid_Farokhzad
|
| gptkbp:bfsLayer |
6
|